MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acr.25445

Медицинская библиотека · Arthritis care & research · 2024

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN).

Sanchez-Rodriguez Alain, Meade-Aguilar Jose Antonio, Yang Jeffrey X, Figueroa-Parra Gabriel, Hanson Andrew C, Langenfeld Hannah E, Thanarajasingam Uma, Chamberlain Alanna M, Greenlund Kurt J, Barbour Kamil E, Crowson Cynthia S, Duarte-García Alí

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

We aimed to characterize presentation and care pathways of patients with systemic lupus erythematosus (SLE), and delays in access to SLE-specialized care.

METHODS

We included patients with incident SLE from the Lupus Midwest Network registry. Time from the first medical encounter for SLE clinical manifestation to access to SLE-specialized care, physician diagnosis, and treatment was estimated. Delays were defined as ≥6 months to access specialized care. We compared SLE manifestations, disease activity, and Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage indexes (SDI) between patients with and without delays. Logistic regression models assessed associations with delays.

RESULTS

The study included 373 patients with SLE. The median time to access SLE-specialized care was 1.1 (95% confidence interval [CI] 0.9-1.5) months, time to diagnosis was 30.6 (95% CI 18.9-48.1) months, and time to treatment initiation was 4.7 (95% CI 3.9-8.4) months. Approximately 25% of patients (93 out of 373) experienced delays accessing specialized care, which were associated with fewer SLE manifestations at first SLE-related encounter (fewer than two SLE domains; 92% vs 72%, P < 0.001). Patients with mucocutaneous or musculoskeletal manifestations were less likely to experience delays, whereas hematologic (odds ratio [OR] 1.71, 95% CI 1.03-2.84) or antiphospholipid antibodies domains (OR 6.05, 95% CI 2.46-14.88) were associated with delays. Delays were associated with damage at first access to SLE-specialized care (SDI ≥1; 30% vs 7%, P < 0.001).

CONCLUSION

Patients follow a heterogeneous pathway to receive care. One-fourth of patients experienced delays accessing SLE-specialized care, which was associated with disease-related damage. Fewer manifestations, hematologic manifestations, or antiphospholipid antibodies were associated with delays.

Для цитирования: Sanchez-Rodriguez Alain, Meade-Aguilar Jose Antonio, Yang Jeffrey X, Figueroa-Parra Gabriel, Hanson Andrew C, Langenfeld Hannah E, Thanarajasingam Uma, Chamberlain Alanna M, Greenlund Kurt J, Barbour Kamil E, Crowson Cynthia S, Duarte-García Alí. Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN).. Arthritis care & research. 2024. DOI: 10.1002/acr.25445.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.